Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(2R)-2-Propyloctanoic acid----1件: 2 💬
2(6R)-4, 5, 6, 7 - tetrahydro-N6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate----1件: 2 💬
3(R)-(-)-2-Propyloctaroic acid----1件: 2 💬
41.0 MIU IL-2 per day1件: Human interleukin-2---1件: 2 💬
518F-OP-801----1件: 2 💬
61H-Pyrazol1件: Pyrazole---5件: 2, 28, 46, 75, 154 💬
72.0 MIU IL-2 per day1件: Human interleukin-2---1件: 2 💬
8201600930----1件: 2 💬
9250 mg CK-2017357----2件: 2, 11 💬
103-methyl-1-phenyl-4, 5-dihydro-1H-pyrazol-5-one.1件: Pyrazole---1件: 2 💬
113K3A-APC Protein----1件: 2 💬
124 cholesten-3-one, oxime----1件: 2 💬
134-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-benzamide, methane sulphonic acid salt. AB1010base1件: Methane---1件: 2 💬
144-cholesten-3-one, oxime----2件: 2, 3 💬
1540 mg GA----2件: 2, 13 💬
1640 mg glatiramer acetate2件: Acetate,
Glatiramer		---2件: 2, 13 💬
175% glucose water solution2件: Dextrose, unspecified form,
Water		1件: Water 💬 --1件: 2 💬
18500 mg CK-2017357----2件: 2, 11 💬
196-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one----1件: 2 💬
209-CIS, 12-CIS-11,11-D2-LINOLEIC ACID ETHYL ESTER1件: Linoleic acid---2件: 2, 5 💬
21[11C]MPC6827----1件: 2 💬
22[18F] GE-180----1件: 2 💬
23[18F]DPA-714 PET----1件: 2 💬
24[18F]PBR06----1件: 2 💬
25AB 1003----1件: 2 💬
26AB1010----6件: 2, 5, 6, 13, 46, 96 💬
27Abacavir1件: Abacavir1件: Abacavir 💬 --4件: 2, 135, 265, 325 💬
28ABBV-CLS-7262----1件: 2 💬
29Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
30Acetylcarnitine1件: Acetylcarnitine---2件: 2, 265 💬
31ACIDO TAUROURSODESOSSICOLICO----1件: 2 💬
32Acthar1件: Corticotropin1件: Corticotropin 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222 💬
33Actos 15 mg1件: Pioglitazone1件: Pioglitazone 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2 💬
34Actos 30 mg1件: Pioglitazone1件: Pioglitazone 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2 💬
35Actos 45 mg1件: Pioglitazone1件: Pioglitazone 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2 💬
36AL0011件: Latozinemab1件: Latozinemab 💬 1件: SORT1 💬 3件: Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬2件: 2, 127 💬
37Albumin----3件: 2, 20, 51 💬
38Albutein 5%1件: Albumin human1件: Albumin human 💬 --1件: 2 💬
39Albúmina humana----1件: 2 💬
40All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine----1件: 2 💬
41All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-----1件: 2 💬
42AlloRx----8件: 2, 6, 13, 46, 51, 85, 90, 226 💬
43ALPHA-LIPOIC ACID1件: Lipoic acid---2件: 2, 13 💬
44ALS patients genetic characterization----1件: 2 💬
45ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109 💬
46ALZT-OP1a (cromolyn)1件: Cromoglicic acid1件: Cromoglicic acid 💬 --1件: 2 💬
47AMDX2011P----2件: 2, 6 💬
48Amivita----1件: 2 💬
49AMSC----1件: 2 💬
50AMX0035----2件: 2, 233 💬
51Anakinra1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬16件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬
52Anti-(misfolded human superoxide dismutase 1) human IgG1m3 monoclonal antibody----1件: 2 💬
53ANX0051件: ANX005---3件: 2, 8, 61 💬
54AP----4件: 2, 6, 13, 299 💬
55AP-101----1件: 2 💬
56APL-2----5件: 2, 61, 62, 66, 222 💬
57APO-P001----1件: 2 💬
58ARIMOCLOMOL1件: Arimoclomol1件: Arimoclomol 💬 --3件: 2, 15, 19 💬
59Arundic Acid1件: Arundic acid1件: Arundic acid 💬 --1件: 2 💬
60Aspaveli1件: Pegcetacoplan1件: Pegcetacoplan 💬 1件: C3 💬 17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬3件: 2, 62, 222 💬
61AstroRx----1件: 2 💬
62Atropine1件: Atropine1件: Atropine 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 2 💬
63Autologous Adipose-derived Mesenchymal Stromal Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 2 💬
64Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded----1件: 2 💬
65Autologous adult bone marrow mononuclear cells unexpanded----1件: 2 💬
66Autologous bone marrow mononucleated cells----1件: 2 💬
67Autologous bone marrow-derived stem cells----1件: 2 💬
68Autologous mesenchymal stem cells----5件: 2, 6, 13, 17, 46 💬
69Autologous Mesenchymal stem cells (MSCs)----1件: 2 💬
70Autologous MSC-NTF cells----1件: 2 💬
71Autologous T-regulatory lymphocytes----1件: 2 💬
72AVP-923----3件: 2, 6, 13 💬
73Azilect1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬4件: 2, 5, 6, 17 💬
74AZILECT® 1 mg Tabletten1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬 		1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 2 💬
75Baclofen1件: Baclofen1件: Baclofen 💬 2件: GABBR1,
GABBR2 💬 		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
76Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
77Basiliximab1件: Basiliximab1件: Basiliximab 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬5件: 2, 50, 97, 222, 228 💬
78Beta Hydroxybutyrate Ester----1件: 2 💬
79Betamethasone1件: Betamethasone1件: Betamethasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬8件: 2, 28, 46, 65, 83, 90, 96, 235 💬
80Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days3件: Acetate,
Betamethasone,
Phosphate ion		1件: Betamethasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 2 💬
81BHV-0223----1件: 2 💬
82BIIB050 / KNS-760704----1件: 2 💬
83BIIB050/KNS-760704----1件: 2 💬
84BIIB067----1件: 2 💬
85BIIB067 (ISIS666853)----1件: 2 💬
86BIIB067 (Tofersen)1件: Tofersen1件: Tofersen 💬 1件: SOD1 💬 8件: Amyotrophic lateral sclerosis, Chemical carcinogenesis - reactive oxygen species, Huntington disease, Longevity regulating pathway - multiple species, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Peroxisome, Prion disease 💬1件: 2 💬
87BIIB078----1件: 2 💬
88BIIB100----1件: 2 💬
89BIIB105----1件: 2 💬
90Biologic: IC14 (monoclonal antibody against human CD14)----1件: 2 💬
91BIOTIN1件: Biotin1件: Biotin 💬 --5件: 2, 8, 10, 13, 20 💬
92Blood sample and environmental survey----1件: 2 💬
93BLZ945----1件: 2 💬
94Bosutinib1件: Bosutinib1件: Bosutinib 💬 2件: ABL1,
SRC 💬 		49件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬2件: 2, 67 💬
95Bosutinib (Phase 1 part)1件: Bosutinib1件: Bosutinib 💬 2件: ABL1,
SRC 💬 		49件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 2 💬
96Bosutinib (Phase 2 part)1件: Bosutinib1件: Bosutinib 💬 2件: ABL1,
SRC 💬 		49件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 2 💬
97Botox1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 2, 6, 13, 47, 51, 149, 226 💬
98BOTOX 100 UNITES ALLERGAN (PR1)1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 2 💬
99Botox injection1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 2, 47 💬
100BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: Botulinum toxin type A 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬
101Botulinum toxin type B1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬3件: 2, 6, 51 💬
102Botulinum toxin type B (Myobloc)1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 2, 6 💬
103BRX-345----2件: 2, 15 💬
104Butylphthalide1件: Butylphthalide---4件: 2, 6, 18, 22 💬
105Caffeine1件: Caffeine2件: Caffeine ,
Caffeine hydrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 21, 46, 78, 96, 97, 265 💬
106Calogen----1件: 2 💬
107Cannabis1件: Medical Cannabis---7件: 2, 6, 13, 19, 90, 96, 97 💬
108Cannabis Sativa extract Oromucosal spray1件: Medical Cannabis---1件: 2 💬
109Cannabis, Medical1件: Medical Cannabis---5件: 2, 6, 13, 96, 97 💬
110CARBOLITHIUM----1件: 2 💬
111CARBOLITHIUM*100CPS 150MG----1件: 2 💬
112Carbonate1件: Carbonate ion---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬
113Carbonate de lithium1件: Carbonate ion---1件: 2 💬
114CBD----13件: 2, 6, 8, 13, 36, 46, 51, 140, 144, 145, 156, 158, 206 💬
115CC100----1件: 2 💬
116Ceftriaxone1件: Ceftriaxone1件: Ceftriaxone 💬 --4件: 2, 6, 46, 97 💬
117Celecoxib1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬10件: 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 💬
118Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in ALS patients----1件: 2 💬
119CENSAVUDINE1件: Censavudine1件: Censavudine 💬 --2件: 2, 127 💬
120Cimetidine1件: Cimetidine1件: Cimetidine 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬2件: 2, 254 💬
121Cimetidine plus Dexpramipexole2件: Cimetidine,
Dexpramipexole		2件: Cimetidine ,
Dexpramipexole 💬 		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
HRH2 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
122Ciprofloxacin1件: Ciprofloxacin1件: Ciprofloxacin 💬 --5件: 2, 60, 96, 97, 299 💬
123Cistanche Total Glycosides----1件: 2 💬
124CK-2017357----1件: 2 💬
125CK-2017357 (Part A)----1件: 2 💬
126CK-2017357 (Part B)----1件: 2 💬
127CK-21271071件: Reldesemtiv1件: Reldesemtiv 💬 1件: TNNC2 💬 1件: Calcium signaling pathway 💬1件: 2 💬
128CK0803----1件: 2 💬
129CK2017357----1件: 2 💬
130Clenbuterol1件: Clenbuterol1件: Clenbuterol 💬 1件: ADRB2 💬 9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 1, 2, 6, 256 💬
131CLS----1件: 2 💬
132CNM-Au8----2件: 2, 13 💬
133CNMAu8----1件: 2 💬
134CNS10-NPC-GDNF----1件: 2 💬
135Coenzyme Q101件: Ubidecarenone1件: Ubidecarenone 💬 --11件: 2, 5, 6, 8, 10, 18, 46, 57, 113, 214, 215 💬
136COLCHICINA1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 2 💬
137COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 2 💬
138Colchicine1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬7件: 2, 42, 46, 56, 93, 210, 266 💬
139Colchicine 1 MG Oral Tablet1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 2 💬
140Collection of biological sample (blood and/or CSF)----2件: 2, 6 💬
141Combination Product: Active treatment with dual therapy----1件: 2 💬
142Control group----4件: 2, 13, 46, 70 💬
143Copegus1件: Ribavirin1件: Ribavirin 💬 --1件: 2 💬
144Copper1件: Copper---4件: 2, 169, 170, 171 💬
145Corticotropin1件: Corticotropin1件: Corticotropin 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 2, 13, 46, 75, 81, 84, 222 💬
146Creatine1件: Creatine---11件: 1, 2, 5, 6, 8, 46, 49, 50, 113, 156, 201 💬
147Creatine Monohydrate1件: Creatine---4件: 2, 8, 113, 156 💬
148Creatinine1件: Creatinine1件: Creatinine 💬 --5件: 2, 46, 60, 70, 222 💬
149Cromolyn1件: Cromoglicic acid1件: Cromoglicic acid 💬 --3件: 2, 85, 98 💬
150Cu(II)ATSM----2件: 2, 6 💬
151Curcumin1件: Curcumin---10件: 2, 13, 46, 67, 74, 94, 96, 97, 139, 299 💬
152Células madre mesenquimales de tejido adiposo autólogo----1件: 2 💬
153Células Mesenquimales de tejido adiposo----1件: 2 💬
154Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea----1件: 2 💬
155Daraprim1件: Pyrimethamine1件: Pyrimethamine 💬 --2件: 2, 4 💬
156Darunavir1件: Darunavir1件: Darunavir 💬 --1件: 2 💬
157DaTSCAN1件: Ioflupane I-123---3件: 2, 5, 6 💬
158Dazucorilant 150 mg----1件: 2 💬
159Dazucorilant 300 mg----1件: 2 💬
160DEFERIPRONE1件: Deferiprone1件: Deferiprone 💬 --6件: 2, 6, 18, 120, 122, 233 💬
161Deferiprone DR1件: Deferiprone1件: Deferiprone 💬 --2件: 2, 6 💬
162Dexdor1件: Dexmedetomidine1件: Dexmedetomidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬4件: 2, 4, 6, 70 💬
163DEXMEDETOMIDINE1件: Dexmedetomidine1件: Dexmedetomidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
164Dexpramipexole1件: Dexpramipexole1件: Dexpramipexole 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
165Dexpramipexole (dose 1)1件: Dexpramipexole1件: Dexpramipexole 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
166Dexpramipexole (dose 2)1件: Dexpramipexole1件: Dexpramipexole 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
167Dexpramipexole Dichydrochloride1件: Dexpramipexole1件: Dexpramipexole 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
168Dexpramipexole Dihydrochloride1件: Dexpramipexole1件: Dexpramipexole 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
169Dextran1件: Dextran1件: Dextran 1 💬 --4件: 2, 62, 96, 97 💬
170Dextran Sodium Sulfur Salt 5, Mw 5 kDa. a type of Low Molecular Weight Dextran Sulfate (LMW-DS)2件: Dextran,
Sulfate ion		1件: Dextran 1 💬 --1件: 2 💬
171DEXTRAN SULFATE SODIUM2件: Dextran,
Sulfate ion		1件: Dextran 1 💬 --1件: 2 💬
172Dextromethorphan1件: Dextromethorphan1件: Dextromethorphan 💬 6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬
173Dextromethorphan HBr and quinidine sulfate3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 2 💬
174Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
175Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
176DNL343----1件: 2 💬
177DNL747----1件: 2 💬
178Dolutegravir1件: Dolutegravir1件: Dolutegravir 💬 --2件: 2, 265 💬
179Dolutegravir, Abacavir and Lamivudine3件: Abacavir,
Dolutegravir,
Lamivudine		3件: Lamivudine ,
Abacavir ,
Dolutegravir 💬 		--1件: 2 💬
180DPA----5件: 2, 6, 13, 85, 127 💬
181Dronabinol1件: Dronabinol1件: Dronabinol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬5件: 2, 13, 46, 271, 298 💬
182Dutasterida1件: Dutasteride1件: Dutasteride 💬 2件: SRD5A1,
SRD5A2 💬 		3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬1件: 2 💬
183Dutasteride1件: Dutasteride1件: Dutasteride 💬 2件: SRD5A1,
SRD5A2 💬 		3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬2件: 1, 2 💬
184E0302 (mecobalamin)1件: Mecobalamin1件: Mecobalamin 💬 --1件: 2 💬
185EBIXA1件: Memantine1件: Memantine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬3件: 2, 6, 13 💬
186EDARAVONE1件: Edaravone1件: Edaravone 💬 --3件: 2, 6, 22 💬
187Edaravone (Radicava®/Radicava ORS®)1件: Edaravone1件: Edaravone 💬 --1件: 2 💬
188EH301 (Nicotinamide Riboside/Pterostilbene)2件: Nicotinamide,
Nicotinamide riboside		1件: Niacinamide 💬 --1件: 2 💬
189Endocannabinoid palmitoylethanolamide (PEA)1件: Palmidrol1件: Palmidrol 💬 --1件: 2 💬
190Engensis----1件: 2 💬
191EPERISONE1件: Eperisone1件: Eperisone 💬 --1件: 2 💬
192EPI-5891件: EPI-589---2件: 2, 6 💬
193EPREX IV SC 1FL 1ML 40000 UI----1件: 2 💬
194EPREX*1SIR 40000UI/ML 1ML----2件: 2, 18 💬
195Eril®----1件: 2 💬
196Erythropoetin (EPO)----1件: 2 💬
197ERYTHROPOIETIN1件: Erythropoietin---9件: 2, 6, 13, 18, 22, 47, 70, 95, 96 💬
198Escitalopram1件: Escitalopram1件: Escitalopram 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 2, 6, 13, 46 💬
199ESKETAMINE1件: Esketamine1件: Esketamine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬3件: 2, 4, 70 💬
200Ezogabine1件: Ezogabine1件: Ezogabine 💬 5件: KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬 		6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬2件: 2, 144 💬
201F 18 T807----2件: 2, 127 💬
202FAB122----1件: 2 💬
203FamC-1----1件: 2 💬
204Fasudil1件: Fasudil1件: Fasudil 💬 2件: ROCK1,
ROCK2 💬 		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 2, 5, 7, 51 💬
205Fasudil (WP-0512)1件: Fasudil1件: Fasudil 💬 2件: ROCK1,
ROCK2 💬 		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
206FASUDIL HYDROCHLORIDE1件: Fasudil1件: Fasudil 💬 2件: ROCK1,
ROCK2 💬 		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
207Febuxostat1件: Febuxostat1件: Febuxostat 💬 1件: XDH 💬 6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬3件: 2, 6, 13 💬
208Fecal microbiota transplantation----5件: 2, 66, 94, 96, 97 💬
209Fenilbutirato----1件: 2 💬
210Fig1件: Fig---1件: 2 💬
211Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
212Fixed dose combination Ciprofloxacin/Celecoxib2件: Celecoxib,
Ciprofloxacin		2件: Ciprofloxacin ,
Celecoxib 💬 		1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 2 💬
213FLX-787-ODT----1件: 2 💬
214FLX-787-ODT (orally disintigrating tablet)----1件: 2 💬
215Fycompa1件: Perampanel1件: Perampanel 💬 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬 		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬2件: 2, 144 💬
216G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬16件: 2, 6, 11, 13, 16, 22, 47, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬
217G04CB02----1件: 2 💬
218GDC-01341件: GDC-0134---1件: 2 💬
219Gilenya1件: Fingolimod1件: Fingolimod 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 2, 13, 14 💬
220Glatiramer1件: Glatiramer---4件: 2, 13, 96, 156 💬
221Glucose2件: D-glucose,
Dextrose, unspecified form		1件: Glucose 💬 --12件: 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 💬
222GM6041件: Alirinetide---1件: 2 💬
223Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬
224Gold Nanocrystals1件: Gold---3件: 2, 6, 13 💬
225Granulocyte - colony stimulating factor (G-CSF)1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 2 💬
226Granulocyte Colony Stimulating Factor1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬6件: 2, 28, 36, 57, 65, 85 💬
227Growth hormone1件: Somatotropin---14件: 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299 💬
228Growth Hormone (Somatropin)1件: Somatotropin---2件: 2, 78 💬
229GSK1223249----2件: 2, 13 💬
230GUANA2015----1件: 2 💬
231GUANABENZ1件: Guanabenz1件: Guanabenz 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 2, 13 💬
232GUANABENZ ACETATO1件: Guanabenz1件: Guanabenz 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 2 💬
233HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---5件: 2, 6, 13, 14, 46 💬
234High-caloric fatty diet----1件: 2 💬
235HK-001----1件: 2 💬
236Human albumin1件: Albumin human1件: Albumin human 💬 --2件: 2, 96 💬
237HUMAN ALBUMIN SOLUTION1件: Albumin human1件: Albumin human 💬 --1件: 2 💬
238Human autologous mesenchymal stem cells----2件: 2, 13 💬
239Human Neural Stem Cells----2件: 2, 13 💬
240Huolingshengji Granules----1件: 2 💬
241HYNR-CS inj----1件: 2 💬
242HYNR-CS-Allo----1件: 2 💬
243HYNRCS-Allo inj----1件: 2 💬
244Hyperpolarized [1-13C]pyruvate----2件: 2, 67 💬
245I-1231件: Iodide I-123---2件: 2, 6 💬
246I-123] ADAM1件: Iodide I-123---1件: 2 💬
247IBUDILAST1件: Ibudilast1件: Ibudilast 💬 8件: CYSLTR1,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PTGIR 💬 		16件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 13 💬
248IC14----1件: 2 💬
249Icerguastat1件: Icerguastat---1件: 2 💬
250IFB-088----1件: 2 💬
251IFB-088 50mg/day----1件: 2 💬
252IL-21件: Human interleukin-2---5件: 2, 46, 49, 53, 56 💬
253ILB----1件: 2 💬
254ILB: 100mg/ml solution for injection and infusion----1件: 2 💬
255IMMUNOGLOBULIN G----8件: 2, 11, 13, 14, 49, 50, 63, 65 💬
256Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy----1件: 2 💬
257Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer----1件: 2 💬
258Incobotulinum Toxin A----3件: 2, 6, 13 💬
259Inosine1件: Inosine1件: Inosine 💬 --5件: 2, 6, 13, 17, 122 💬
260Insulin like growth factor, type 1----1件: 2 💬
261INTERLEUKIN-21件: Human interleukin-2---10件: 2, 35, 49, 50, 53, 55, 65, 96, 97, 162 💬
262Intra venous injection of stem cell----1件: 2 💬
263Intrathecal autologous stem cell----1件: 2 💬
264Intrathecal injection----1件: 2 💬
265Intravenous administration of 1 million of MSC----1件: 2 💬
266Intravenous administration of 2 million of MSC----1件: 2 💬
267Intravenous administration of 4 million of MSC----1件: 2 💬
268Intraventricular injection----1件: 2 💬
269Ioflupane 123I----1件: 2 💬
270ION363----1件: 2 💬
271IPL344----1件: 2 💬
272ISIS 333611----1件: 2 💬
273Isocaloric Diet----2件: 2, 83 💬
274Jevity 1.0----1件: 2 💬
275Jevity 1.5----1件: 2 💬
276Ketanest----3件: 2, 4, 70 💬
277Ketanest-S----3件: 2, 4, 70 💬
278KetoCal----1件: 2 💬
279KNS-760704----1件: 2 💬
280L-Serine1件: Serine1件: Serine 💬 --1件: 2 💬
281Lacosamide1件: Lacosamide1件: Lacosamide 💬 2件: SCN3A,
SCN9A 💬 		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
282Lactose1件: Lactose2件: Anhydrous lactose ,
Lactose 💬 		--6件: 2, 6, 13, 97, 228, 310 💬
283Lamivudine1件: Lamivudine1件: Lamivudine 💬 --7件: 2, 26, 42, 46, 135, 265, 325 💬
284Lenograstim1件: Lenograstim1件: Lenograstim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬7件: 2, 13, 16, 18, 19, 57, 65 💬
285Lenzumestrocel1件: Lenzumestrocel---1件: 2 💬
286Leuprolide1件: Leuprolide---5件: 1, 2, 3, 51, 76 💬
287Levetiracetam1件: Levetiracetam1件: Levetiracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬5件: 2, 4, 6, 13, 307 💬
288LEVOSIMENDAN1件: Levosimendan1件: Levosimendan 💬 2件: PDE3A,
PDE3B 💬 		11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
289Linoleic acid1件: Linoleic acid---4件: 2, 5, 13, 299 💬
290LIORESAL*50CPR 10MG1件: Baclofen1件: Baclofen 💬 2件: GABBR1,
GABBR2